The Impact of Epigenetics on Leukemia and Current Target Therapy

Obadiah Audu Sunday, Abdulrahman Yakubu, Festus Uchechukwu Onuigwe, Ibrahim Kalle Kwaifa, Mukhtar Mainasara Yeldu, Isaiah Audu, Isiyaku Adamu and Gayus Habila Kumbo
Additional contact information
Obadiah Audu Sunday: Department of Hematology, School of Medical Laboratory Science, College of Health Sciences, UDU, Sokoto
Abdulrahman Yakubu: Department of Hematology, School of Medical Laboratory Science, College of Health Sciences, UDU, Sokoto
Festus Uchechukwu Onuigwe: Department of Hematology, School of Medical Laboratory Science, College of Health Sciences, UDU, Sokoto
Ibrahim Kalle Kwaifa: Department of Hematology, School of Medical Laboratory Science, College of Health Sciences, UDU, Sokoto
Mukhtar Mainasara Yeldu: Department of Hematology, School of Medical Laboratory Science, College of Health Sciences, UDU, Sokoto
Isaiah Audu: Department of Hematology, School of Medical Laboratory Science, College of Health Sciences, UDU, Sokoto
Isiyaku Adamu: Department of Immunology, School of Medical Laboratory Science, College of Health Sciences, UDU, Sokoto
Gayus Habila Kumbo: Department of Medical Laboratory Sciences, Faculty of Basic Medical Sciences University of Lagos, Nigeria

International Journal of Research and Scientific Innovation, 2024, vol. 11, issue 4, 835-849

Abstract: Epigenetics is the study of how gene expression is regulated by factors other than the DNA sequence itself. Unlike genetic changes, epigenetic changes are reversible and do not change the DNA sequence but change how the body reads the sequence if more methylation is involved. Leukaemia is a type of blood cancer that affects the production and maturation of white blood cells caused by genetic mutations, chromosomal abnormalities, and epigenetic changes that disrupt the normal regulation of haematopoiesis. DNA methylation, histone modifications, and non-coding RNAs are the main epigenetic mechanism that influences the development and function of different cell types, as well as their response to environmental stimuli. These mechanisms affect the way leukaemic cells communicate with the surrounding components of the tumour, and the immune microenvironment, and play key roles in leukaemia progression. It is becoming more and more obvious that abnormal post-translational modifications, in addition to genetic mutations, have resulted in DNA changes, linked to leukaemogenesis. This review aims to evaluate the epigenetic mechanism and targeted therapy using organic food elements such as Curcumin (Turmeric), Genistein (Soybean), Tea Polyphenols (Green Tea), Resveratrol (Grapes), and Sulforaphane (Cruciferous Vegetables) to obliterate leukaemia.

Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.rsisinternational.org/journals/ijrsi/d ... -issue-4/835-849.pdf (application/pdf)
https://rsisinternational.org/journals/ijrsi/artic ... rent-target-therapy/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bjc:journl:v:11:y:2024:i:4:p:835-849

Access Statistics for this article

International Journal of Research and Scientific Innovation is currently edited by Dr. Renu Malsaria

More articles in International Journal of Research and Scientific Innovation from International Journal of Research and Scientific Innovation (IJRSI)
Bibliographic data for series maintained by Dr. Renu Malsaria ().